Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

NCT00327990 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Ibandronate
DRUG: Alendronate

Sponsor

GlaxoSmithKline